Quarterly report pursuant to Section 13 or 15(d)

Stock-based Compensation (Details)

v2.4.0.8
Stock-based Compensation (Details) (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Dec. 31, 2013
Stock-based awards weighted average assumptions [Abstract]          
Dividend yield (in hundredths) 0.00% 0.00% 0.00% 0.00%  
Expected volatility (in hundredths) 88.00% 92.00% 93.00% 92.00%  
Risk free interest rate (in hundredths) 1.79% 1.43% 1.72% 0.87%  
Expected term 5 years 7 months 6 days 5 years 7 months 6 days 5 years 7 months 6 days 5 years 7 months 6 days  
Stock option activity [Roll Forward]          
Options outstanding beginning of period (in shares)     7,218,241    
Granted (in shares)     1,846,089    
Exercised (in shares)     (862,622)    
Forfeited, expired or cancelled (in shares)     (417,567)    
Options outstanding end of period (in shares) 7,784,141   7,784,141   7,218,241
Options exercisable at end period (in shares) 4,729,821   4,729,821    
Stock options activity, weighted average exercise price [Roll Forward]          
Options outstanding, beginning of period (in dollars per share)     $ 8.42    
Granted (in dollars per share)     $ 6.75    
Exercised (in dollars per share)     $ 4.02    
Forfeited, expired or cancelled (in dollars per share)     $ 15.45    
Options outstanding, end of period (in dollars per share) $ 8.13   $ 8.13   $ 8.42
Options exercisable weighted average exercise price (in dollars per share) $ 10.24   $ 10.24    
Additional Disclosures [Abstract]          
Options outstanding weighted average remaining contractual term beginning of period     6 years 11 months 19 days   6 years 9 months
Options outstanding weighted average remaining contractual term end of period     6 years 11 months 19 days   6 years 9 months
Options exercisable weighted average remaining contractual term     5 years 9 months 11 days    
Options outstanding, aggregate intrinsic value at beginning of period     $ 18,213    
Options outstanding, aggregate intrinsic value at end of period 5,609   5,609   18,213
Options exercisable, aggregate intrinsic value 3,511   3,511    
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]          
Total stock-based compensation expense 3,537 1,227 9,885 3,946  
Research and Development [Member]
         
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]          
Total stock-based compensation expense 1,765 474 5,124 1,904  
Selling, General and Administrative Expenses [Member]
         
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]          
Total stock-based compensation expense $ 1,772 $ 753 $ 4,761 $ 2,042  
Restricted Stock Units (RSUs) [Member]
         
Unvested RSU activity [Roll Forward]          
Unvested balance beginning of period (in shares)     1,738,037    
Granted (in shares)     1,493,594    
Vested (in shares)     (693,566)    
Forfeited (in shares)     (178,416)    
Unvested balance end of period (in shares) 2,359,649   2,359,649    
Unvested RSU activity, weighted average grant date fair value [Roll Forward]          
Unvested balance, beginning of period (in dollars per share)     $ 2.73    
Granted (in dollars per share)     $ 6.51    
Vested (in dollars per share)     $ 3.96    
Forfeited (in dollars per share)     $ 4.12    
Unvested balance, end of period (in dollars per share) $ 5.00   $ 5.00    
Long Term Incentive Plan [Member] | Stock Options [Member]
         
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Vesting period     4 years    
Stock option activity [Roll Forward]          
Granted (in shares)     1,846,089    
Long Term Incentive Plan [Member] | Restricted Stock Units (RSUs) [Member]
         
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Vesting period     3 years    
Stock option activity [Roll Forward]          
Granted (in shares)     1,493,594